CV Sciences (CVSI) Other Non-Current Liabilities (2015 - 2024)

CV Sciences' (CVSI) quarterly Other Non-Current Liabilities came in at $38000.0 in Q3 2024, down 60.0% quarter-over-quarter from $95000.0 in Q2 2024.

CV Sciences (CVSI) Other Non-Current Liabilities (2015 - 2024) Analysis & Trends

CV Sciences has disclosed Other Non-Current Liabilities across 7 years of filings, most recently posting $38000.0 for Q3 2024.

  • Other Non-Current Liabilities for Q3 2024 came in at $38000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2024 was $38000.0 (changed N/A YoY), and the FY2023 annual result was $105000.0, changed N/A from the prior year.
  • Other Non-Current Liabilities came in at $38000.0 for Q3 2024 at CV Sciences, down from $95000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $171000.0 in Q1 2020 to a low of $38000.0 in Q3 2024.
  • The 3-year median for Other Non-Current Liabilities is $103000.0 (2024), against an average of $102400.0.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 CV Sciences - - 1.56 Mn

Historic Data

Download Data
DateValue
Sep 30, 2024 38,000.00
Jun 30, 2024 95,000.00
Mar 31, 2024 103,000.00
Dec 31, 2023 105,000.00
Mar 31, 2020 171,000.00
Dec 31, 2019 406,000.00
Jun 30, 2019 406,000.00
Sep 30, 2018 1.23 Mn
Jun 30, 2018 1.19 Mn
Mar 31, 2018 1.16 Mn
Dec 31, 2017 1.07 Mn
Jun 30, 2017 29,300.00
Mar 31, 2017 29,300.00
Dec 31, 2015 250,000.00